| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Kaempferol | Benign Prostatic Hyperplasia | 1 | PM | 34129879 | 📋 | Kaempferol inhibits benign prostatic hyperplasia by resisting the action of androgen |
| Kaempferol | Bladder Cancer | 2 | PM | 34836005 | 📋 | Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature |
| Kaempferol | Bladder Cancer | 1 | PM | 30309003 | 📋 | Kaempferol Attenuates ROS-Induced Hemolysis and the Molecular Mechanism of Its Induction of Apoptosis on Bladder Cancer |
| Kaempferol | Diabetic Nephropathy | 5 | PM | 36530875 | 📋 | Kaempferol attenuated diabetic nephropathy by reducing apoptosis and promoting autophagy through AMPK/mTOR pathways |
| Kaempferol | Diabetic Nephropathy | 4 | PM | 33625930 | 📋 | Kaempferol attenuates diabetic nephropathy in streptozotocin-induced diabetic rats by a hypoglycaemic effect and concomitant activation of the Nrf-2/Ho-1/antioxidants axis |
| Kaempferol | Diabetic Nephropathy | 3 | PM | 33152432 | 📋 | Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression: the role of TRAF6 in diabetic nephropathy |
| Kaempferol | Diabetic Nephropathy | 2 | PM | 33102606 | 📋 | Protective Effects of Two Safflower Derived Compounds, Kaempferol and Hydroxysafflor Yellow A, on Hyperglycaemic Stress-Induced Podocyte Apoptosis via Modulating of Macrophage M1/M2 Polarization |
| Kaempferol | Diabetic Nephropathy | 1 | PM | 32563017 | 📋 | Kaempferol in Ameliorating Diabetes-Induced Fibrosis and Renal Damage: An in Vitro and in Vivo Study in Diabetic Nephropathy Mice Model |
| Kaempferol | Kidney Fibrosis | 1 | PM | 36274411 | 📋 | Kaempferol inhibits renal fibrosis by suppression of the sonic hedgehog signaling pathway |
| Kaempferol | Kidney Stones | 1 | PM | 33852977 | 📋 | Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway |
| Kaempferol | Nephrotoxicity | 4 | PM | 36481400 | 📋 | Kaempferol attenuates doxorubicin-induced renal tubular injury by inhibiting ROS/ASK1-mediated activation of the MAPK signaling pathway |
| Kaempferol | Nephrotoxicity | 3 | PM | 35355181 | 📋 | The ameliorative effect of kaempferol against CdCl 2- mediated renal damage entails activation of Nrf2 and inhibition of NF-kB |
| Kaempferol | Nephrotoxicity | 2 | PM | 35227143 | 📋 | Apigenin and kaempferol as novel renoprotective agent against cisplatin-induced toxicity: an in vitro study |
| Kaempferol | Nephrotoxicity | 1 | PM | 33149706 | 📋 | Effect of Kaempferol on Tacrolimus-Induced Nephrotoxicity and Calcineurin B1 Expression Level in Animal Model |
| Kaempferol | Renal Cell Carcinoma | 2 | PM | 28924370 | 📋 | Kaempferol Inhibits the Invasion and Migration of Renal Cancer Cells through the Downregulation of AKT and FAK Pathways |
| Kaempferol | Renal Cell Carcinoma | 1 | PM | 24399193 | 📋 | Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling |
